Guangzhou Pharmaceutical Group Co., Ltd., the controlling shareholder, received a civil ruling from Beijing No.1 Intermediate People's Court on July 3, 20 12. According to the ruling, Beijing No.1 Intermediate People's Court ruled on May 9, 20 12 that Hongdao (Group) Co., Ltd. applied to cancel the arbitration award made by China International Economic and Trade Arbitration Commission, and rejected Hongdao Group's application to cancel the arbitration award made by the International Economic and Trade Arbitration Commission (20 12).